US5324571083 - Common Stock
ELI LILLY & CO
NYSE:LLY (5/17/2024, 7:10:55 PM)
After market: 770.75 +0.75 (+0.1%)770
-1.12 (-0.15%)
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The company is headquartered in Indianapolis, Indiana and currently employs 39,000 full-time employees. The firm discovers, develops, manufactures and markets products in the human pharmaceutical products segment. Its diabetes products include Basaglar, Humalog, Humulin, Jardiance, Mounjaro and Trulicity. Its oncology products consist of Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, and others. Its immunology products include Olumiant, Taltz, oral IL-17 inhibitors and others. Its neuroscience products include Cymbalta, Emgality, and Zyprexa. Its other therapies consist of Bamlanivimab and etesevimab, Bebtelovimab and Forteo. The company manufactures and distributes its products through facilities in the United States, including Puerto Rico, and other countries. The firm's subsidiary is POINT Biopharma Global Inc., which is a radiopharmaceutical company with a pipeline of clinical and preclinical stage radioligand therapies in development for the treatment of cancer. The firm's products are sold in over 110 countries.
ELI LILLY & CO
Lilly Corporate Ctr, Drop Code 1094, Lilly Corporate Ctr
Indianapolis INDIANA 46285
P: 13172762000
CEO: David A. Ricks
Employees: 39000
Website: https://www.lilly.com/
Eli Lilly's biggest growth drivers today are its weight loss drugs.
Eli Lilly's biggest growth drivers today are its weight loss drugs.
Plus, an Eli Lilly executive on how to solve the weight loss drug shortage
Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), Eli Lilly and Company (LLY) and Costco Wholesale Corporation (COST), as well a micro-cap stock Koss Corporation (KOSS).
Investors want to know where 2024's top-performing pharma stocks are headed in the second half of the year for good reason.
Don't miss out on profit potential of these stocks to buy. Explore three top stocks poised to unlock gains in a surging market.
Here you can normally see the latest stock twits on LLY, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: